Kingdon Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
LP
Kingdon Capital Management's AGN Position: Q4 2019 in Review
Kingdon Capital Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 60,216 shares — an estimated $10.1M sold.
Kingdon Capital Management first reported a position in AGN in Q3 2013 and held it in 13 quarters. The position peaked at $48.8M in Q4 2014. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.
- Kingdon Capital Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
- Kingdon Capital Management sold 60,216 Allergan plc shares in Q4 2019, an estimated $10.1M.
- Kingdon Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 13 quarters.
- Kingdon Capital Management's Allergan plc position peaked at $48.8M in Q4 2014.
- 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.
Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.